METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF ROSUVASTATIN CALCIUM AND EZETIMIBE IN BULK AND PHARMACEUTICAL DOSAGE FORMS BY RP-HPLC

Authors

  • Matta Jyothi, Gope Edward Raju, Doonaboyina Raghava, Kavala Nageswara Rao Author

DOI:

https://doi.org/10.48047/drb28c83

Keywords:

Rosuvastatin Calcium, Ezetimibe, RP-HPLC, Method Validation, Fixed-Dose Combination, Quality Control

Abstract

Rosuvastatin Calcium, an HMG-CoA reductase inhibitor, and Ezetimibe, a cholesterol absorption inhibitor, are commonly co-formulated to provide synergistic lipid-lowering effects in hypercholesterolemia

Downloads

Download data is not yet available.

References

Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., … Braunwald, E. (2015). Ezetimibe added to statin therapy afteracute coronary syndromes. The New England Journal of Medicine, 372(25), 2387–2397. https://doi.org/10.1056/NEJMoa1410489

Downloads

Published

2025-09-27

Issue

Vol. 54 No. 5 (2025): Year 2025 ,Volume 54 Issue 5

Section

Original

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF ROSUVASTATIN CALCIUM AND EZETIMIBE IN BULK AND PHARMACEUTICAL DOSAGE FORMS BY RP-HPLC (Matta Jyothi, Gope Edward Raju, Doonaboyina Raghava, Kavala Nageswara Rao , Trans.). (2025). Cuestiones De Fisioterapia, 54(5), 1314-1326. https://doi.org/10.48047/drb28c83